385 related articles for article (PubMed ID: 29346445)
1. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients' skin fibroblasts.
Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
PLoS One; 2019; 14(2):e0211647. PubMed ID: 30716086
[TBL] [Abstract][Full Text] [Related]
3. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics.
Doherty EL; Aw WY; Warren EC; Hockenberry M; Whitworth CP; Krohn G; Howell S; Diekman BO; Legant WR; Nia HT; Hickey AJ; Polacheck WJ
Acta Biomater; 2023 Aug; 166():346-359. PubMed ID: 37187299
[TBL] [Abstract][Full Text] [Related]
5. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
Zoppi N; Ritelli M; Colombi M
Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers-Danlos syndrome.
Shimaoka Y; Kosho T; Wataya-Kaneda M; Funakoshi M; Suzuki T; Hayashi S; Mitsuhashi Y; Isei T; Aoki Y; Yamazaki K; Ono M; Makino K; Tanaka T; Kunii E; Hatamochi A
Br J Dermatol; 2010 Oct; 163(4):704-10. PubMed ID: 20518783
[TBL] [Abstract][Full Text] [Related]
7. Deciphering disease signatures and molecular targets in vascular Ehlers-Danlos syndrome through transcriptome and miRNome sequencing of dermal fibroblasts.
Chiarelli N; Cinquina V; Martini P; Bertini V; Zoppi N; Venturini M; Ritelli M; Colombi M
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166915. PubMed ID: 37827202
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts.
Müller GA; Hansen U; Xu Z; Griswold B; Talan MI; McDonnell NB; Briest W
FASEB J; 2012 Feb; 26(2):668-77. PubMed ID: 22038052
[TBL] [Abstract][Full Text] [Related]
9. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.
Kuivaniemi H; Tromp G
Gene; 2019 Jul; 707():151-171. PubMed ID: 31075413
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of extracellular matrix and Lysyl Oxidase in Ehlers-Danlos syndrome type IV skin fibroblasts.
Foehr R; Anderson K; Dombrowski O; Foehr A; Foehr ED
Orphanet J Rare Dis; 2024 Jan; 19(1):9. PubMed ID: 38183136
[TBL] [Abstract][Full Text] [Related]
12. Genetic aspects of the vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan.
Watanabe A; Kosho T; Wada T; Sakai N; Fujimoto M; Fukushima Y; Shimada T
Circ J; 2007 Feb; 71(2):261-5. PubMed ID: 17251678
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome.
Morissette R; Schoenhoff F; Xu Z; Shilane DA; Griswold BF; Chen W; Yang J; Zhu J; Fert-Bober J; Sloper L; Lehman J; Commins N; Van Eyk JE; McDonnell NB
Circ Cardiovasc Genet; 2014 Feb; 7(1):80-8. PubMed ID: 24399159
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress and collagenous formation anomalies in vascular-type Ehlers-Danlos syndrome via electron microscopy.
Ishikawa S; Kosho T; Kaminaga T; Miyamoto M; Hamasaki Y; Yoshihara S; Hayashi S; Igawa K
J Dermatol; 2021 Apr; 48(4):481-485. PubMed ID: 33523542
[TBL] [Abstract][Full Text] [Related]
15. Atypical COL3A1 variants (glutamic acid to lysine) cause vascular Ehlers-Danlos syndrome with a consistent phenotype of tissue fragility and skin hyperextensibility.
Ghali N; Baker D; Brady AF; Burrows N; Cervi E; Cilliers D; Frank M; Germain DP; Hulmes DJS; Jacquemont ML; Kannu P; Lefroy H; Legrand A; Pope FM; Robertson L; Vandersteen A; von Klemperer K; Warburton R; Whiteford M; van Dijk FS
Genet Med; 2019 Sep; 21(9):2081-2091. PubMed ID: 30837697
[TBL] [Abstract][Full Text] [Related]
16. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
[TBL] [Abstract][Full Text] [Related]
17. Clinical, structural, biochemical and X-ray crystallographic correlates of pathogenicity for variants in the C-propeptide region of the COL3A1 gene.
Stembridge NS; Vandersteen AM; Ghali N; Sawle P; Nesbitt M; Pollitt RC; Ferguson DJ; Holden S; Elmslie F; Henderson A; Hulmes DJ; Pope FM
Am J Med Genet A; 2015 Aug; 167A(8):1763-72. PubMed ID: 25846194
[TBL] [Abstract][Full Text] [Related]
18. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
[TBL] [Abstract][Full Text] [Related]
20. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome.
Frank M; Albuisson J; Ranque B; Golmard L; Mazzella JM; Bal-Theoleyre L; Fauret AL; Mirault T; Denarié N; Mousseaux E; Boutouyrie P; Fiessinger JN; Emmerich J; Messas E; Jeunemaitre X
Eur J Hum Genet; 2015 Dec; 23(12):1657-64. PubMed ID: 25758994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
